ProfileJobs

C. R. Bard

Healthmedical devicesmedtechsurgical solutions
C. R. Bard, Inc. is a multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties. The Company markets its products and services worldwide to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. 
Revenue(Q1, 2017)
$938.8 M
Market capitalization(2017-09-21)
$23.2 B
Company Growth (employees)
Type
Public
HQ
New Providence, US
Founded
1907
Size (employees)
16,300 (est)
Website
crbard.com
C. R. Bard was founded in 1907 and is headquartered in New Providence, US

C. R. Bard Office Locations

C. R. Bard has offices in New Providence, Salt Lake City, Covington, Tempe and in 2 other locations
New Providence, US (HQ)
730 Central Ave
Stuart, US
2979 SE Gran Park Way
New Providence, US
111 Spring Ridge Dr
Warwick, US
100 Crossings Blvd
Tempe, US
1415 W 3rd St
Covington, US
8195 Industrial Blvd
Show all (7)

C. R. Bard Data and Metrics

C. R. Bard Financial Metrics

C. R. Bard's revenue was reported to be $938.8 m in Q1, 2017
USD

Revenue (Q1, 2017)

938.8 m

Gross profit (Q1, 2017)

584.6 m

Gross profit margin (Q1, 2017), %

62%

Net income (Q1, 2017)

178.1 m

Market capitalization (21-Sep-2017)

23.2 b

Cash (31-Mar-2017)

890.7 m
C. R. Bard's current market capitalization is $23.2 b.
USDFY, 2015FY, 2016

Revenue

3.4 b3.7 b

Revenue growth, %

3%9%

Cost of goods sold

1.3 b1.4 b

Gross profit

2.1 b2.3 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

827.1 m830 m819.7 m859.8 m865.7 m873.5 m931.5 m941.9 m938.8 m

Cost of goods sold

320.7 m308.9 m311.2 m333.7 m336.3 m320.4 m351 m352.2 m354.2 m

Gross profit

506.4 m521.1 m508.5 m526.1 m529.4 m553.1 m580.5 m589.7 m584.6 m

Gross profit Margin, %

61%63%62%61%61%63%62%63%62%
show all
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.1 b960.1 m950.5 m905 m

Inventories

356.2 m376.2 m413.7 m483 m

Current Assets

2.1 b2 b2.1 b2.3 b

Goodwill

1.1 b1.1 b1.1 b1.3 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

996.1 m971.7 m1 b1.1 b1 b765 m797.8 m996.4 m890.7 m

Inventories

374.3 m379.9 m377.8 m383.6 m381.1 m439.7 m470.5 m487.7 m497.2 m

Current Assets

2 b2 b2 b2.2 b2.1 b2.1 b2.2 b2.3 b2.3 b

Goodwill

1.1 b1.1 b1.1 b1.1 b1.1 b1.3 b1.3 b1.3 b1.3 b
show all
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

689.8 m294.5 m135.4 m531.4 m

Depreciation and Amortization

146.4 m174.1 m193.1 m213.4 m

Accounts Receivable

23.5 m21.3 m(18 m)(25.1 m)

Inventories

(36 m)(54 m)(33 m)(83.7 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(119.4 m)131.3 m139.8 m(54.7 m)(86 m)116.2 m159.2 m96.4 m178.1 m

Inventories

383.6 m381.1 m439.7 m470.5 m487.7 m497.2 m

Accounts Payable

69.9 m73.3 m96.8 m91.5 m95.7 m102 m
show all
USDY, 2017

Revenue/Employee

57.6 k
Show all financial metrics

C. R. Bard Market Value History

Market Position of C. R. Bard

Competitors

St. Jude Medical
Health - Subsidiary
STAAR Surgical
Health - Public
Teleflex Incorporated
Health - Public
Integra LifeSciences
Health - Public
Compare competitors

Traffic Overview of C. R. Bard

C. R. Bard Online and Social Media Presence

C. R. Bard News and Updates

April 24, 2017

Global markets are ripping higher after the French election

US stock index futures rose sharply on Monday, tracking European and Asian stocks, as investors breathed a sigh of relief after Centrist candidate and market favorite Emmanuel Macron won the first round of the French election. Polls showed pro-EU Macron is expected to beat r…

C. R. Bard Company Life and Culture

You may also be interested in